What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals
Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates
Read More 5 minute read General business news What the Kraken listing of RAIN reveals about Enlivex Therapeutics Ltd.’s risk appetite and capital strategy Find out how Enlivex Therapeutics Ltd.’s RAIN token listing on Kraken could reshape treasury liquidity, risk perception, and investor sentiment. bySoujanya RaviFebruary 10, 2026